CNTB · Connect Biopharma Holdings Ltd · Executive Compensation
$0.89
-0.01 (-1.37%)
At close · Oct 7
Return incl. dividend (before tax)
Market Cap
$79.41M
Shares
62.97M
Volume · Oct 6
1.84M
Avg daily vol (3M)
3.77M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Kan Chen, Ph.D. | Board of Directors of the Company | Resigned | 2025-12-23 |
| James A. Schoeneck | director | Appointed | 2025-07-22 |